CCI
ITCI

Columbus Circle Investors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Columbus Circle Investors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-533,636
Closed -$6.93M – 189
2019
Q2 		$6.93M Buy
533,636
+146,245
+38% +$1.88M 0.18% 118
2019
Q1 		$4.72M Sell
387,391
-78,453
-17% -$1M 0.12% 123
2018
Q4 		$5.31M Sell
465,844
-27,764
-6% -$448K 0.15% 116
2018
Q3 		$10.7M Sell
493,608
-31,894
-6% -$667K 0.21% 132
2018
Q2 		$9.29M Sell
525,502
-30,654
-6% -$622K 0.19% 142
2018
Q1 		$11.7M Buy
556,156
+233,107
+72% +$4.54M 0.24% 129
2017
Q4 		$4.68M Buy
323,049
+165,744
+105% +$2.56M 0.09% 151
2017
Q3 		$2.48M Buy
+157,305
New +$2.31M 0.04% 214
2017
Q2 		– Sell
-380,911
Closed -$6.19M – 299
2017
Q1 		$6.19M Sell
380,911
-138,197
-27% -$2M 0.09% 180
2016
Q4 		$7.83M Buy
519,108
+128,458
+33% +$1.81M 0.1% 169
2016
Q3 		$5.95M Sell
390,650
-161,454
-29% -$6.53M 0.06% 200
2016
Q2 		$21.4M Buy
552,104
+157,498
+40% +$5.66M 0.21% 116
2016
Q1 		$11M Buy
394,606
+31,135
+9% +$1.04M 0.1% 171
2015
Q4 		$19.6M Buy
363,471
+118,629
+48% +$5.98M 0.16% 142
2015
Q3 		$9.8M Buy
+244,842
New +$7.99M 0.08% 194

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Columbus Circle Investors's ITCI Position: Q3 2019 in Review

Columbus Circle Investors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2019, closing a stake of 533,636 shares — an estimated $6.93M sold.

Columbus Circle Investors first reported a position in ITCI in Q3 2015 and held it in 15 quarters. The position peaked at $21.4M in Q2 2016. 126 funds tracked by Wall St. Rank hold ITCI as of Q3 2019.

  • Columbus Circle Investors reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2019 after selling out during the quarter.
  • Columbus Circle Investors sold 533,636 Intra-Cellular Therapies Inc. shares in Q3 2019, an estimated $6.93M.
  • Columbus Circle Investors first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 15 quarters.
  • Columbus Circle Investors's Intra-Cellular Therapies Inc. position peaked at $21.4M in Q2 2016.
  • 126 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2019.

Based on Columbus Circle Investors's 13F filing for Q3 2019, filed 29 Oct 2019.